Bosentan is used

Go down

Bosentan is used

Post by cisco on Wed Apr 28, 2010 11:45 am

Bosentan (BOZENTAN) is a dual endothelin receptor antagonist important in the treatment of pulmonary artery hypertension (PAH). Bosentan is indicated mainly for the treatment of pulmonary hypertension. In 2007, Tracleer (bosentan) was approved in the European Union also for reducing the number of new digital ulcers in patients with systemic sclerosis and ongoing digital ulcer disease. In the United States, Tracleer is indicated for the treatment of pulmonary arterial hypertension (WHO Group I) in patients with WHO Class II-IV symptoms, to improve exercise capacity and decrease the rate of clinical worsening.


Male Number of posts : 78
Religion : Non-Muslim
Department : Archi
Session : 2001
Residence Status : Boarder
Registration date : 2010-04-14

View user profile

Back to top Go down

Back to top

Permissions in this forum:
You cannot reply to topics in this forum